Page last updated: 2024-10-19

niacinamide and Pulmonary Veno Occlusive Disease

niacinamide has been researched along with Pulmonary Veno Occlusive Disease in 1 studies

nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.

Research Excerpts

ExcerptRelevanceReference
"The present study is the first report of the effectiveness of sorafenib in the treatment of pulmonary veno-occlusive disease (PVOD)."7.78Sorafenib is effective in the treatment of pulmonary veno-occlusive disease. ( Fukuda, K; Kataoka, M; Satoh, T; Yanagisawa, R; Yoshino, H, 2012)
"The present study is the first report of the effectiveness of sorafenib in the treatment of pulmonary veno-occlusive disease (PVOD)."3.78Sorafenib is effective in the treatment of pulmonary veno-occlusive disease. ( Fukuda, K; Kataoka, M; Satoh, T; Yanagisawa, R; Yoshino, H, 2012)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kataoka, M1
Yanagisawa, R1
Fukuda, K1
Yoshino, H1
Satoh, T1

Other Studies

1 other study available for niacinamide and Pulmonary Veno Occlusive Disease

ArticleYear
Sorafenib is effective in the treatment of pulmonary veno-occlusive disease.
    Cardiology, 2012, Volume: 123, Issue:3

    Topics: Aged; Benzamides; Drug Therapy, Combination; Female; Hemodynamics; Humans; Imatinib Mesylate; Niacin

2012